Antidepressants for neuropathic pain
58 results
1 - 58
Antidepressants for neuropathic pain 
Antidepressants for neuropathic pain: Cochrane systematic review- Diabetic neuropathy
- Trigeminal neuralgia and other facial pain
- Chronic pain
- Venlafaxine for neuropathic pain in adults: Cochrane systematic review
- Milnacipran for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Antidepressants for non‐specific low back pain Edited (no change to conclusions)
- Lamotrigine for chronic neuropathic pain and fibromyalgia in adults: Cochrane systematic review
- Nortriptyline for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Amitriptyline for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Imipramine for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Antidepressants for chronic non‐cancer pain in children and adolescents Stable (no update expected for reasons given in 'What's new')
- Cannabis-based medicines for chronic neuropathic pain in adults: Cochrane systematic review
- Desipramine for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Gabapentin for acute and chronic pain: Cochrane systematic review
- Carbamazepine for chronic neuropathic pain and fibromyalgia in adults Stable (no update expected for reasons given in 'What's new')
- Gabapentin for chronic neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
Anticonvulsants, SNRIs, and rubefacients are best initial choices for chronic pain caused by diabetic neuropathy or postherpetic neuralgia- Methadone for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Meralgia paraesthetica
- Anticonvulsant drugs for acute and chronic pain: Cochrane systematic review
- Venlafaxine in the treatment of neuropathic pain
- Pregabalin for neuropathic pain in adults Stable (no update expected for reasons given in 'What's new')
- Amitriptyline for fibromyalgia in adults Stable (no update expected for reasons given in 'What's new')
- Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia: Cochrane systematic review
- Topical lidocaine for the treatment of postherpetic neuralgia: Cochrane systematic review
- Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews
- Pharmacologic interventions for treating phantom limb pain Stable (no update expected for reasons given in 'What's new')
- Cannabis product ineffective for diabetic peripheral neuropathy
- Interventions for treating chronic pelvic pain in women: Cochrane systematic review
- Interventions for treating burning mouth syndrome: Cochrane systematic review
- Duloxetine versus other anti-depressive agents for depression: Cochrane systematic review
- Low back pain
- Neck and shoulder pain
- Antiepileptic drugs for chronic non‐cancer pain in children and adolescents Stable (no update expected for reasons given in 'What's new')
- Milnacipran for pain in fibromyalgia in adults: Cochrane systematic review
- Vulvodynia
- Opioids for chronic non‐cancer pain in children and adolescents Stable (no update expected for reasons given in 'What's new')
- Paracetamol (acetaminophen) for chronic non‐cancer pain in children and adolescents Stable (no update expected for reasons given in 'What's new')
- Multiple sclerosis (MS)
- Non‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents Stable (no update expected for reasons given in 'What's new')
- Pharmacological treatment of depression